Recent studies have demonstrated additive effects of steroids and p38 inhibitors in reducing cytokine release from bronchoalveolar lavage (BAL) macrophages and PBMCs from asthmatics[26] and COPD patients[27]. This evidence concerns the gene MAPK14 and chronic obstructive pulmonary disease.